Investigating the role of microglial IGF1 in the development of epilepsy

Microglial IGF1 in epileptogenesis

NIH-funded research Albany Medical College · NIH-11131892

This study is looking at how certain brain cells called microglia might play a role in causing epilepsy by affecting a specific signaling pathway, and it aims to find new ways to help prevent seizures.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College NIH-funded
Lab location1 site (Albany, United States)
Project IDNIH-11131892 on NIH RePORTER

What this research studies

This research focuses on understanding how microglial cells, a type of immune cell in the brain, contribute to the development of epilepsy, particularly through the activation of a signaling pathway known as mTOR. The study aims to explore how elevated mTOR activity in microglia affects the expression of Insulin-like Growth Factor 1 (IGF1) and its potential role in promoting epileptic seizures. By using animal models, researchers will investigate the mechanisms by which microglial signaling influences neuronal activity and seizure development, providing insights into new therapeutic targets for epilepsy prevention.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a history of neurological insults or genetic predispositions that may lead to epilepsy.

Not a fit: Patients with epilepsy caused solely by factors unrelated to mTOR signaling or microglial activity may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or reduce the severity of epilepsy in patients.

How similar studies have performed: While the role of microglia in epilepsy is underexplored, preliminary findings suggest that targeting the mTOR/IGF1 pathway may offer new avenues for treatment, indicating a novel approach in this area.

Where this research is happening

Albany, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.